Cibinqo
Disease-modifying antirheumatic drugs (DMARDs) are medicines used to treat inflammatory and autoimmune rheumatic diseases, particularly rheumatoid arthritis. Unlike painkillers and anti-inflammatory medicines, DMARDs target the underlying disease processes, helping reduce inflammation, slow disease progression and prevent permanent joint damage. They may also improve physical function and long-term quality of life. DMARDs are classified into conventional synthetic DMARDs, biological DMARDs and targeted synthetic DMARDs. Common examples include methotrexate, sulfasalazine, hydroxychloroquine, leflunomide, adalimumab, etanercept and tofacitinib.